Inve India ▾

Caprihans India share price & results

Caprihans India Ltd.· Capital Goods· Industrials

Results to
Jun 2026
Ownership as of
Jun 2026

Maharashtra-based manufacturer of PVC and PVDC barrier films and laminates used in pharmaceutical blister packaging, serving domestic and export pharma customers.

Company research is public. Sign in to keep your own companies, notes and cases.

Reported

The figures, each with its period

Each figure keeps its basis and period; nothing is filled in.

MetricValueChangeBasisPeriodNote
Revenue221 ₹ crore+21.7% YoYQuarterly, as filedQuarter to Jun 2026Revenue from operations as filed.
Operating margin15.3 %+10.2 pts YoYOperating profit / revenueQuarter to Jun 2026For the quarter; a change is in percentage points.
Net profit6.2 ₹ crore—Quarterly, as filedQuarter to Jun 2026Profit after tax as filed. The year-earlier figure was zero or a loss, so no percentage is shown.
Return on equity-9.21 %+2.8 ptsFY Mar 2026 vs FY Mar 2025Trailing twelve monthsTTM to Jun 2026Adjusted profit attributable to owners ÷ average owners’ equity.
Free cash flow margin15.61 %−5.5 ptsFY Mar 2026 vs FY Mar 2025Fiscal yearFY ending Mar 2026(Operating cash flow − fixed-asset purchases + disposals) ÷ revenue.
Revenue growth (YoY)0.46 %−11.7 ptsFY Mar 2026 vs FY Mar 2025Trailing twelve monthsTTM to Jun 2026Revenue change against the same period one year earlier.

Source: Inve data from filed results; ratios from the Screener-verified panel · to Jun 2026

Price

₹9 +2.86% · +₹0.25

Last close 17 Jan 2002 · NSE · INR · Source: Inve

Performance −25.0% 90D

₹10.0₹12.0₹14.028 Oct7 Nov18 Nov28 Nov9 Dec19 Dec30 Dec10 Jan

90D: ₹12 on 28 Oct 2001 → ₹9. High ₹15.45 (27 Nov 2001), low ₹8.75 (16 Jan 2002).

Previous close
₹8.75
Market cap
₹192 Cr
52-week range
₹8.75 – ₹15.45
Return on equity (TTM to Jun 2026)
-9.21%

Overview

Symbol
NSE:CAPRIHANS
Industry
Industrials
Exchange
NSE
Currency
INR

What Caprihans India Ltd. does

Based on the company's own presentations, annual report and earnings calls.

Caprihans India manufactures PVC and PVDC-coated films and multi-layer laminates used as blister packaging for solid oral dosage pharmaceutical products, supplying domestic and global pharmaceutical companies and packaging converters. Pharma packaging solutions manufacturing and sale is the company's sole reportable business segment. Its DSIR-recognised in-house R&D units develop halogen-free blister films and recyclable mono-material laminates, and it operates a wholly-owned German subsidiary, Bilcare Research GmbH (Frankfurt), to grow its customer base in Europe and North America.

Segments

  • Pharma Packaging
Manufacturing plants
3 — Rajgurunagar (Pune), Nasik, Ambernath (Thane); as of Aug 2025
In-house R&D units (DSIR-recognised)
2 (Nasik and Ambernath/Thane factories)
Overseas subsidiary
Bilcare Research GmbH, Frankfurt, Germany (100%-owned; serves Europe/North America customers)
Quality & regulatory certifications
ISO 15378:2017, ISO 14001:2015, ISO 45001:2018; systems aligned with EU, US FDA & WHO GMP
Reportable business segments
1 (Pharma Packaging)
Solar power capacity (Pune/Khed plant)
2.6 MW
Founded 1946Headquarters Rajgurunagar, Pune, MaharashtraEmployees 540 (FY25) Company website

Your own record

Start an Inve Case for Caprihans India Ltd.

Free account: one company. Everything above stays public.

Write why you follow Caprihans India Ltd. and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.

What an account adds

Keep reading

Other Capital Goods companies

All Capital Goods companies → · Capital Goods earnings growth →

Learn to analyse Caprihans India Ltd.

Guides on how to read this kind of business and the numbers that matter.